InsidersTradesSigma
Discover the full record of transactions filed by Schneyer Mark C., Chief Financial Officer. Director active across 1 companies, notably Acadia Pharmaceuticals INC. Cumulatively, 2 filings have been recorded. The latest transaction was filed on 8 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Mark C. Schneyer is the Chief Financial Officer and Executive Vice President of Acadia Pharmaceuticals Inc. He is responsible for the financial management of the company, including budgeting and financial strategy. His experience in the pharmaceutical sector allows him to play a key role in Acadia's growth and sustainability.